OgBench: A Framework for Evaluating Graph Neural Networks on Omics Data

📅 2026-05-15
📈 Citations: 0
Influential: 0
📄 PDF

career value

207K/year
🤖 AI Summary
Existing graph neural network (GNN) benchmarks predominantly focus on scenarios where the number of graphs far exceeds the number of nodes per graph, overlooking the typical “few samples, large graphs” (n ≪ p) setting prevalent in omics data. To address this gap, this work proposes OgBench, the first benchmarking framework tailored to this regime, which establishes a standardized end-to-end pipeline transforming raw omics data into diverse, feature-rich graphs. OgBench integrates classical GNNs, large-graph-optimized models, MLPs, and traditional machine learning methods. Empirical results reveal that state-of-the-art GNNs often fail to outperform simple baselines under this setting, challenging the common assumption that graph structure inherently improves predictive performance. OgBench provides a reliable benchmark and open-source ecosystem to foster the development of novel architectures for biological graph learning.
📝 Abstract
Graph Neural Networks (GNNs) have become the dominant framework for inductive graph-level learning. Yet most benchmarks focus on the regime $n \gg p$, where the number of graphs $n$ greatly exceeds the number of nodes per graph $p$. This overlooks biological domains such as omics, which operate in the opposite $n \ll p$ regime, characterized by large graphs of genes, transcripts, or proteins across few patient samples. This raises the question: \textit{how do GNNs perform in this low-sample, high-node omics setting?} We introduce \texttt{OgBench} (Omics-Graph Bench), the first benchmarking platform for graph-level prediction in the $n \ll p$ regime characteristic of omics data. We provide a standardized, end-to-end modular infrastructure from raw omics data to families of featured graphs with varied structural properties. We benchmark classical GNNs, as well as GNNs designed for large graphs and omics applications, alongside MLPs and machine learning baselines to establish reference performances. Our results show that widely used GNNs often do not outperform simple MLPs and classical baselines. These findings challenge the prevailing assumption that graph structure inherently adds value in this domain, fostering a critical reassessment of current learning paradigms. Ultimately, by exposing these limitations, OgBench provides the open-source ecosystem necessary for the community to develop and validate novel architectures explicitly tailored for biological graphs. The code is available at https://github.com/geometric-intelligence/ogbench.
Problem

Research questions and friction points this paper is trying to address.

Graph Neural Networks
omics data
low-sample high-node regime
graph-level prediction
benchmarking
Innovation

Methods, ideas, or system contributions that make the work stand out.

Graph Neural Networks
Omics Data
Benchmarking
Low-sample High-node Regime
Biological Graphs
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid